News Hub | News Direct

Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
Article thumbnail Digital Asset Direct

MGC Pharmaceuticals to "keep chipping away" after first CannEpil delivery

MGC Pharmaceuticals Ltd

Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

June 02, 2023 10:17 AM Eastern Daylight Time

Video
Article thumbnail Digital Asset Direct

Immunic ultimately hoping to "offer patients a new kind of treatment" for multiple sclerosis

Immunic Inc

Contact Details Proactive United States +1 347-449-0879 action@proactiveinvestors.com

May 31, 2023 07:42 AM Eastern Daylight Time

Video
Article thumbnail Digital Asset Direct

HealthBeacon signs "very big deal" in key US market

HealthBeacon PLC

Contact Details Proactive Investors UK +44 20 7989 0813 uk@proactiveinvestors.com

May 30, 2023 11:02 AM Eastern Daylight Time

Video
Article thumbnail Digital Asset Direct

Creo Medical Group "really pleased" with first human trial of lung lesion treatment

Creo Medical Group PLC

Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

May 26, 2023 11:07 AM Eastern Daylight Time

Video
Article thumbnail Digital Asset Direct

Poolbeg Pharma's new NED looking at "new opportunities" for the business

Poolbeg Pharma PLC

Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

May 26, 2023 07:32 AM Eastern Daylight Time

Video
Article thumbnail Digital Asset Direct

ImmuPharma "looking forward with quiet confidence" to FDA response

ImmuPharma PLC

Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

May 24, 2023 11:08 AM Eastern Daylight Time

Video
Article thumbnail Digital Asset Direct

Voyager Life "now capable of dealing with multinational customers"

Voyager Life PLC

Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

May 24, 2023 11:03 AM Eastern Daylight Time

Video
Article thumbnail Digital Asset Direct

Oxford Cannabinoid Technologies: Phase 1 approval for lead chronic pain drug

Oxford Cannabinoid Technologies Holdings PLC

Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

May 24, 2023 10:59 AM Eastern Daylight Time

Video
Article thumbnail Digital Asset Direct

Creo Medical Group "gaining a level of acceptance" in endoscopy

Creo Medical Group PLC

Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

May 23, 2023 11:15 AM Eastern Daylight Time

Video
12345 ... 8